SS
Shaishav Sandal
About Shaishav Sandal
Data last updated:
Shaishav Sandal is a Director at Alna Biotech Private Limited (since 2020) and Director at Ventus Pharmaceuticals Private Limited (since 2016). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹67.36 Cr; the largest is Alna Biotech Private Limited at ₹57.47 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Dec 2020 | 2009 | ₹57.47 Cr (FY 2024) | Active | |
| Director | 24 Feb 2016 | 2011 | ₹9.89 Cr (FY 2025) | Active |
Board colleagues of Shaishav Sandal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagjit Singh | 02600110 | Alna Biotech Private Limited | Managing Director |
| Girjesh Singh Kumar | 03612229 | Ventus Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shaishav Sandal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shaishav Sandal
Shaishav Sandal currently holds 2 directorships: Alna Biotech Private Limited (Director, since 16 Dec 2020, revenue ₹57.47 Cr (FY 2024)); Ventus Pharmaceuticals Private Limited (Director, since 24 Feb 2016, revenue ₹9.89 Cr (FY 2025)).
Shaishav Sandal was first appointed on 24 Feb 2016 as Director at Ventus Pharmaceuticals Private Limited. The most recent appointment on record is 16 Dec 2020 at Alna Biotech Private Limited.
The 2 current companies of Shaishav Sandal that report revenue have a combined latest revenue of ₹67.36 Cr: Alna Biotech Private Limited ₹57.47 Cr (FY 2024); Ventus Pharmaceuticals Private Limited ₹9.89 Cr (FY 2025).
The current boards of Shaishav Sandal's companies include Jagjit Singh (Alna Biotech Private Limited), Girjesh Singh Kumar (Ventus Pharmaceuticals Private Limited).